Forodesine Hydrochloride

N/A

Report date: 2023/05/05 16:59:02
NMEFirst In Class

Base Information

Drug NameForodesine Hydrochloride
Drug Alias Name呋咯地新Immucillin-Hforodesina呋咯地新盐酸盐盐酸呋咯地新 +[10] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionPurine nucleoside phosphorylase inhibitors
TargetsPurine nucleoside phosphorylase
Therapy Area/IndicationsLymphoma, T-Cell, PeripheralLymphoma, T-Cell, CutaneousLymphoma, Extranodal NK-T-Cell +[12] 
Global Approved IndicationsLymphoma, T-Cell, Peripheral
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2017/03/30
Country/TerritoryCzechiaUnited StatesItaly +[13] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBiocryst Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesMundipharma Kk
Inactive CompaniesMundipharma Research LtdBiocryst Pharmaceuticals Inc
Active IndicationsLymphoma, T-Cell, Peripheral
Inactive IndicationsLymphoma, T-Cell, CutaneousLymphoma, Extranodal NK-T-CellLymphoma, T-Cell +[11] 

Other Information

ATC CodeL01XX
Related LinksWikipediaKEGG